AI Patent Analysis Toolkit
PatentAgility
by KellDann

Examiner Catherine Konopka

Examiner Catherine Konopka appears to be very difficult relative to their art unit, group, tech center, and USPTO peers. Their lifetime grant ratio is 32.9%, they average 2.60 office actions per granted patent, and their rejection profile leans toward ยง103.

Difficulty vs AU Very Hard
Difficulty vs Group Very Hard
Difficulty vs TC Very Hard
Difficulty vs USPTO Very Hard
Average OA / Grant 2.60
Export
Word PDF

Create account to export.

Examiner Details

Observed Examiner Years
6 years (2021-2026)
Phone
(571) 272-0330
Predicted Supervisor
Ram Shukla
Supervisor Phone
(571) 272-0735
Tech Center
1600 - Biotechnology and Organic
Group
1630 - Stem Cells and Nucleic Acid Related Therapy

Metrics

Applications Evaluated
228
Granted Applications
75
Non-Granted Applications
153
Avg OA / Grant
2.60
Last OA Observed
March 2026 (0 months ago)
Art Units Seen
1635 , 1636
Work Groups Seen

Context Comparison

Scope Examiners Lifetime Grant Ratio Avg OA / Grant
This Examiner 1 32.9% 2.60
Art Unit 30 38.3% 2.20
Group 243 38.4% 2.18
Tech Center 1,349 39.5% 2.02
USPTO 16,116 54.8% 1.98

Grant Timeline

0.0% 25.0% 50.0% 75.0% 100.0% 2021 2022 2023 2024 2025 2026
Shaded region marks the last two observed years, where grant outcomes may lag due to recency.
Year Applications Granted Grant Rate
No observed data before 2021; examiner may not yet have been active in the available dataset.
2021 7 3 42.9%
2022 33 17 51.5%
2023 44 25 56.8%
2024 49 26 53.1%
2025 62 4 6.5%
2026 33 0 0.0%

75 family-cache-validated grants; 0 OA-only grant signals.

Rejection Timeline

OA # Office Actions § 101 Percentage § 102 Percentage § 103 Percentage § 112 Percentage
1 215 2.3% 3.3% 44.7% 4.7%
2 131 0.8% 1.5% 51.1% 10.7%
3 82 1.2% 3.7% 46.3% 13.4%
4 44 2.3% 9.1% 45.5% 20.5%
5 20 5.0% 0.0% 60.0% 5.0%
6 13 0.0% 7.7% 61.5% 0.0%
7 6 0.0% 0.0% 100.0% 0.0%
8 4 0.0% 0.0% 100.0% 0.0%
9 3 0.0% 0.0% 100.0% 0.0%
10 1 0.0% 0.0% 100.0% 0.0%

§ 101 Yearly Trend

2024: AI Examples
2025: Aug. Memo
0.0%
2020
0.0%
2021
2.4%
2022
3.0%
2023
1.1%
2024
1.8%
2025
0.0%
2026

Each bar shows the share of this examiner's observed office actions in that year that included a § 101 rejection.